HomeNewsTrendsHealthEight teams of scientists from India and US selected for pursuing research on COVID-19

Eight teams of scientists from India and US selected for pursuing research on COVID-19

The teams will pursue research in areas such as antiviral coatings, immune modulation, tracking SARS CoV-2 in wastewater, disease detection mechanisms, reverse genetics strategies and drug repurposing

August 18, 2020 / 14:13 IST
Representative image

Eight binational teams of researchers from India and the US have been selected for pursuing cutting-edge research in pathogenesis and disease management of COVID-19, according to an official statement on Tuesday.

The teams will pursue research in areas such as antiviral coatings, immune modulation, tracking SARS CoV-2 in wastewater, disease detection mechanisms, reverse genetics strategies and drug repurposing.

The research awards were announced by the Indo-US Science and Technology Forum (IUSSTF), an autonomous bilateral organisation jointly funded by the governments of India and the US, which promotes science, technology, engineering and innovation through substantive interaction among government, academia and industry.

The Department of Science and Technology (DST) under the Ministry of Science and Technology, and the US Department of States are respective nodal departments.

The mission of the Indo-US Science and Technology Forum is to act as a catalyst to promote long-term scientific collaborations between India and the United States through partnerships amongst individual scientists, scientific institutions, and the scientific community at large, the DST statement said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"The eight teams are among the best few who had submitted proposals in response to an invitation of proposals to harness the combined expertise of the Indian and US Science & Technology communities, facilitate partnerships between teams of Indian and US scientists and engineers currently engaged in COVID-related research, and leverage existing infrastructure from both countries to further advance the research and accelerate progress," the statement said.

Ashutosh Sharma, DST Secretary and IUSSTF India Co-Chair, said an overwhelming response in a short time to the special call on COVID-19 demonstrates a wide spectrum of cooperation between India and the US from the basic studies on the behaviour of SARS-Cov-2 virus to its transmission to diagnostics and therapeutic approaches.

"Our existing strong cooperation in S&T on health, energy, artificial intelligence and so on also continues to bring value and attests to the importance of Indo-US collaborations in providing compelling solutions," Sharma said.

Jonathan Margolis, Deputy Assistant Secretary for Science, Space and Health, Bureau of Oceans and International Environmental and Scientific Affairs, US Department of State, and IUSSTF US Co-Chair, said the United States and India were able to quickly mobilise, through IUSSTF, to support jointly developed innovations to fight COVID-19.

"Our people and economies both rely on science and technology to identify tools to address the pressing challenges of the current pandemic,” the statement quoting Margolis said.

PTI
first published: Aug 18, 2020 02:00 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347